神経診断薬の世界市場レポート 2025年

神経診断薬市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.8％で127億9,000万米ドルに成長します。予測期間中、非侵襲的診断技術に対する需要の高まり、神経疾患の有病率の増加、ヘルスケアインフラに対する政府投資の増加、認知度の向上と早期発見への取り組み、個別化医療アプローチの拡大などにより成長が見込まれます。この期間の主な動向には、ポータブルEEG機器の開発、診断精度向上のためのAIの統合、脳画像診断のためのMRI技術の進歩、継続的モニタリングのためのウェアラブルの採用、神経遺伝学的検査の進歩、個別化治療計画のためのリアルタイムデータ解析の利用などがあります。

神経疾患の有病率の増加は、神経診断薬市場の拡大を促進すると予想されます。脳、脊髄、神経に影響を及ぼす神経疾患は、さまざまな認知障害、運動障害、感覚障害をもたらします。これらの障害の増加は主に、人口の高齢化、環境の影響、ライフスタイルの変化、遺伝、診断技術の向上などの要因によるものです。神経診断薬は、これらの疾患の正確な同定、評価、モニタリングに不可欠であり、正確な診断、十分な情報に基づく治療の選択、神経学的問題の効果的な管理を支援します。例えば、2023年4月、国立医学図書館は、670万人のアメリカ人がアルツハイマー病を患っていると報告し、その数は2060年までに1,380万人に増加すると予想されました。このような神経疾患の有病率の増加が、神経診断薬市場を前進させています。

神経診断薬市場の企業は、診断精度を高め、患者の予後を改善するために、高度なソフトウェアアルゴリズムを含む技術革新に注力しています。これらの高度なアルゴリズムは、人工知能（AI）や機械学習技術を使用してデータを処理・分析し、より良い意思決定や診断をサポートします。例えば、2023年10月、米国の医療機器メーカーであるCeribell Inc.は、電気てんかん（ESE）の診断において大きな進歩を示すClarityPro AIアルゴリズムを発表しました。セリベル脳波計システムと統合されたこの先進的なソフトウェアは、機械学習を利用して脳波波形を解析し、発作が疑われる場合にリアルタイムで警告を発します。ClarityProは、スタンドアロン診断用としてFDAの認可を受けた初の急性期医療機器であり、脳活動を継続的にモニタリングし、実用的な洞察を提供することで、臨床医がより迅速かつ十分な情報に基づいた治療決定を下せるよう支援します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界神経診断薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の神経診断薬市場：成長率分析
• 世界の神経診断薬市場の実績：規模と成長, 2019-2024
• 世界の神経診断薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界神経診断薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の神経診断薬市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 診断および画像ソリューション
• 体外診断
• 世界の神経診断薬市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 神経画像技術
• コンピュータ断層撮影（CT）
• 磁気共鳴画像法（MRI）
• 核医学画像診断（PET、SPECT）
• 近赤外線分光イメージング（NIRS）
• 脳波検査（EEG）
• 磁気脳波検査（MEG）
• ボクセルベース形態計測（VBM）
• ニューロインフォマティクス
• 世界の神経診断薬市場状態別、実績と予測, 2019-2024, 2024-2029F, 2034F
• てんかん
• アルツハイマー病
• パーキンソン病
• 脳卒中
• 関節の健康
• その他の条件
• 世界の神経診断薬市場：最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 診断検査室
• 画像センター
• その他の用途
• 世界の神経診断薬市場診断および画像診断ソリューションの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• MRI（磁気共鳴画像）システム
• CT（コンピュータ断層撮影）スキャナ
• EEG（脳波）システム
• EMG（筋電図）システム
• MEG（脳磁図）システム
• PET（陽電子放出断層撮影）スキャナー
• SPECT（単一光子放出コンピュータ断層撮影）スキャナ
• 機能的MRI（fMRI）システム
• 頭蓋内圧モニター
• 世界の神経診断薬市場体外診断薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血液ベースの診断
• 脳脊髄液（CSF）分析
• 遺伝子検査とバイオマーカー
• 神経化学診断
• ポイントオブケア神経診断薬
• 神経変性疾患の診断キット

第7章 地域別・国別分析

• 世界の神経診断薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の神経診断薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 神経診断薬市場：競合情勢
• 神経診断薬市場：企業プロファイル
  • Nihon Kohden Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Cephalon LLC Overview, Products and Services, Strategy and Financial Analysis
  • Stratus Neuro LLC Overview, Products and Services, Strategy and Financial Analysis
  • Cadwell Industries Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Compumedics Limited Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Ceribell Inc.
• CND Life Sciences Inc.
• Lifelines Neuro Inc.
• ANT Neuro B.V.
• Neurovative Diagnostics LLC
• Firefly Neuroscience Inc
• IntraNerve Neuroscience Inc
• NeuroDiagnostics Laboratories LLC
• Advanced Brain Monitoring Inc
• Spes Medica S.r.l.
• BioSignal Group Inc
• Combinostics Inc.
• Deymed Diagnostic LLC
• NeuLine Health Inc.
• Ridge Diagnostics Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 神経診断薬市場2029：新たな機会を提供する国
• 神経診断薬市場2029：新たな機会を提供するセグメント
• 神経診断薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Neurodiagnostics is a medical field focused on diagnosing and monitoring disorders of the nervous system, which includes the brain, spinal cord, and peripheral nerves. It utilizes advanced technologies and tests to evaluate neurological function, detect abnormalities, and help diagnose conditions such as epilepsy, stroke, multiple sclerosis, neuropathies, and other neurological diseases.

The primary types of neurodiagnostic tools are diagnostic and imaging solutions, as well as in-vitro diagnostics. Diagnostic and imaging solutions include medical technologies and services designed to detect health conditions through various imaging techniques and diagnostic tools. Key technologies in this area include neuroimaging, computed tomography (CT), magnetic resonance imaging (MRI), nuclear medicine imaging (PET, SPECT), near-infrared spectroscopic imaging (NIRS), electroencephalography (EEG), magnetoencephalography (MEG), voxel-based morphometry (VBM), and neuroinformatics. These diagnostic tools are vital for treating conditions such as epilepsy, Alzheimer's disease, Parkinson's disease, stroke, joint health problems, and more, and are used in hospitals, clinics, diagnostic laboratories, imaging centers, and other healthcare settings.

The neurodiagnostic market research report is one of a series of new reports from The Business Research Company that provides neurodiagnostic market statistics, including the neurodiagnostic industry's global market size, regional shares, competitors with a neurodiagnostic market share, detailed neurodiagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the neurodiagnostic industry. This neurodiagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The neurodiagnostics market size has grown strongly in recent years. It will grow from $9.17 billion in 2024 to $9.82 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth during the historic period can be attributed to factors such as the rising prevalence of neurological disorders, increased adoption of advanced imaging technologies, the growing geriatric population, heightened awareness of early disease diagnosis, expanding healthcare infrastructure, and increased investments in neuroscience research and development.

The neurodiagnostics market size is expected to see strong growth in the next few years. It will grow to $12.79 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. For the forecast period, growth is expected due to the rising demand for non-invasive diagnostic techniques, the growing prevalence of neurological disorders, higher government investments in healthcare infrastructure, increased awareness and early detection initiatives, and the expansion of personalized medicine approaches. Key trends during this period include the development of portable EEG devices, integration of AI for improved diagnostic accuracy, advancements in MRI technologies for brain imaging, the adoption of wearables for continuous monitoring, advancements in neurogenetic testing, and the use of real-time data analytics for personalized treatment plans.

The growing prevalence of neurological disorders is expected to propel the expansion of the neurodiagnostics market. Neurological disorders, which affect the brain, spinal cord, or nerves, result in various cognitive, motor, and sensory impairments. The increase in these disorders is primarily attributed to factors such as aging populations, environmental influences, lifestyle changes, genetics, and improvements in diagnostic techniques. Neurodiagnostics are crucial for the accurate identification, assessment, and monitoring of these conditions, helping ensure precise diagnoses, informed treatment choices, and effective management of neurological issues. For instance, in April 2023, the National Library of Medicine reported that 6.7 million Americans were living with Alzheimer's disease, a number expected to rise to 13.8 million by 2060. This growing prevalence of neurological conditions is driving the neurodiagnostics market forward.

Companies in the neurodiagnostics market are focusing on technological innovations, including advanced software algorithms, to enhance diagnostic accuracy and improve patient outcomes. These sophisticated algorithms use artificial intelligence (AI) and machine learning techniques to process and analyze data, supporting better decision-making and diagnostics. For example, in October 2023, Ceribell Inc., a US-based medical equipment company, launched the ClarityPro AI algorithm, which represents a significant advancement in diagnosing electrographic status epilepticus (ESE). This advanced software, integrated with the Ceribell EEG system, uses machine learning to analyze EEG waveforms and provide real-time alerts for suspected seizures. ClarityPro is the first acute care device to receive FDA clearance for standalone diagnosis, helping clinicians make quicker, more informed treatment decisions by continuously monitoring brain activity and providing actionable insights.

In July 2022, ArchiMed SAS, a France-based investment firm focused on the healthcare sector, acquired Natus Medical Incorporated for $1.1 billion. This acquisition enhances ArchiMed's position in the neurodiagnostics space by leveraging Natus Medical's expertise in developing medical devices for screening, diagnosing, and treating neurological disorders.

Major players in the neurodiagnostics market are Nihon Kohden Corporation, Cephalon LLC, Stratus Neuro LLC, Cadwell Industries Inc., Compumedics Limited, Ceribell Inc., CND Life Sciences Inc., Lifelines Neuro Inc., ANT Neuro B.V., Neurovative Diagnostics LLC, Firefly Neuroscience Inc, IntraNerve Neuroscience Inc, NeuroDiagnostics Laboratories LLC, Advanced Brain Monitoring Inc, Spes Medica S.r.l., BioSignal Group Inc, Combinostics Inc., Deymed Diagnostic LLC, NeuLine Health Inc., Ridge Diagnostics Inc., Beacon Biosignals Inc., and Intch Inc.

North America was the largest region in the neurodiagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neurodiagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the neurodiagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neurodiagnostics market includes revenues earned by entities by providing services such as electroencephalography (EEG), positron emission tomography (PET), cerebrospinal fluid (CSF) analysis, and sleep apnea diagnosis. The market value includes the value of related goods sold by the service provider or included within the service offering. The neurodiagnostic market consists of sales of transcranial magnetic stimulation (TMS) devices, magnetoencephalography (MEG) systems, polysomnography (PSG) devices, and biosensors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neurodiagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neurodiagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neurodiagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The neurodiagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Diagnostic And Imaging Solutions; In-Vitro Diagnostics
• 2) By Technology: Neuroimaging Technologies; Computed Tomography (CT); Magnetic Resonance Imaging (MRI); Nuclear Medicine Imaging (PET, SPECT); Near Infrared Spectroscopic Imaging (NIRS); Electro-Encephalography (EEG); Magneto-Encephalography (MEG); Voxel Based Morphometry (VBM); Neuroinformatics
• 3) By Condition: Epilepsy; Alzheimer's Disease; Parkinson's Disease; Stroke; Joint Health; Other Conditions
• 4) By End Use : Hospitals And Clinics; Diagnostic Laboratories; Imaging Centers; Other End Uses
• Subsegments:
• 1) By Diagnostic And Imaging Solutions: MRI (Magnetic Resonance Imaging) Systems; CT (Computed Tomography) Scanners; EEG (Electroencephalogram) Systems; EMG (Electromyography) Systems; MEG (Magnetoencephalography) Systems; PET (Positron Emission Tomography) Scanners; SPECT (Single Photon Emission Computed Tomography) Scanners; Functional MRI (fMRI) Systems; Intracranial Pressure Monitors
• 2) By In-Vitro Diagnostics: Blood-Based Diagnostics; Cerebrospinal Fluid (Csf) Analysis; Genetic Testing And Biomarkers; Neurochemical Diagnostics; Point-Of-Care Neurodiagnostics; Diagnostic Kits For Neurodegenerative Disorders
• Companies Mentioned:Nihon Kohden Corporation; Cephalon LLC; Stratus Neuro LLC; Cadwell Industries Inc.; Compumedics Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Neurodiagnostics Market Characteristics

3. Neurodiagnostics Market Trends And Strategies

4. Neurodiagnostics Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Neurodiagnostics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Neurodiagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Neurodiagnostics Market Growth Rate Analysis
• 5.4. Global Neurodiagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Neurodiagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Neurodiagnostics Total Addressable Market (TAM)

6. Neurodiagnostics Market Segmentation

• 6.1. Global Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic And Imaging Solutions
• In-Vitro Diagnostics
• 6.2. Global Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Neuroimaging Technologies
• Computed Tomography (CT)
• Magnetic Resonance Imaging (MRI)
• Nuclear Medicine Imaging (PET, SPECT)
• Near Infrared Spectroscopic Imaging (NIRS)
• Electro-Encephalography (EEG)
• Magneto-Encephalography (MEG)
• Voxel Based Morphometry (VBM)
• Neuroinformatics
• 6.3. Global Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Epilepsy
• Alzheimer's Disease
• Parkinson's Disease
• Stroke
• Joint Health
• Other Conditions
• 6.4. Global Neurodiagnostics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Diagnostic Laboratories
• Imaging Centers
• Other End Uses
• 6.5. Global Neurodiagnostics Market, Sub-Segmentation Of Diagnostic And Imaging Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• MRI (Magnetic Resonance Imaging) Systems
• CT (Computed Tomography) Scanners
• EEG (Electroencephalogram) Systems
• EMG (Electromyography) Systems
• MEG (Magnetoencephalography) Systems
• PET (Positron Emission Tomography) Scanners
• SPECT (Single Photon Emission Computed Tomography) Scanners
• Functional MRI (fMRI) Systems
• Intracranial Pressure Monitors
• 6.6. Global Neurodiagnostics Market, Sub-Segmentation Of In-Vitro Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood-Based Diagnostics
• Cerebrospinal Fluid (Csf) Analysis
• Genetic Testing And Biomarkers
• Neurochemical Diagnostics
• Point-Of-Care Neurodiagnostics
• Diagnostic Kits For Neurodegenerative Disorders

7. Neurodiagnostics Market Regional And Country Analysis

• 7.1. Global Neurodiagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Neurodiagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Neurodiagnostics Market

• 8.1. Asia-Pacific Neurodiagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Neurodiagnostics Market

• 9.1. China Neurodiagnostics Market Overview
• 9.2. China Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Neurodiagnostics Market

• 10.1. India Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Neurodiagnostics Market

• 11.1. Japan Neurodiagnostics Market Overview
• 11.2. Japan Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Neurodiagnostics Market

• 12.1. Australia Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Neurodiagnostics Market

• 13.1. Indonesia Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Neurodiagnostics Market

• 14.1. South Korea Neurodiagnostics Market Overview
• 14.2. South Korea Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Neurodiagnostics Market

• 15.1. Western Europe Neurodiagnostics Market Overview
• 15.2. Western Europe Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Neurodiagnostics Market

• 16.1. UK Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Neurodiagnostics Market

• 17.1. Germany Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Neurodiagnostics Market

• 18.1. France Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Neurodiagnostics Market

• 19.1. Italy Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Neurodiagnostics Market

• 20.1. Spain Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Neurodiagnostics Market

• 21.1. Eastern Europe Neurodiagnostics Market Overview
• 21.2. Eastern Europe Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Neurodiagnostics Market

• 22.1. Russia Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Neurodiagnostics Market

• 23.1. North America Neurodiagnostics Market Overview
• 23.2. North America Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Neurodiagnostics Market

• 24.1. USA Neurodiagnostics Market Overview
• 24.2. USA Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Neurodiagnostics Market

• 25.1. Canada Neurodiagnostics Market Overview
• 25.2. Canada Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Neurodiagnostics Market

• 26.1. South America Neurodiagnostics Market Overview
• 26.2. South America Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Neurodiagnostics Market

• 27.1. Brazil Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Neurodiagnostics Market

• 28.1. Middle East Neurodiagnostics Market Overview
• 28.2. Middle East Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Neurodiagnostics Market

• 29.1. Africa Neurodiagnostics Market Overview
• 29.2. Africa Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Neurodiagnostics Market Competitive Landscape And Company Profiles

• 30.1. Neurodiagnostics Market Competitive Landscape
• 30.2. Neurodiagnostics Market Company Profiles
  • 30.2.1. Nihon Kohden Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Cephalon LLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Stratus Neuro LLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Cadwell Industries Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Compumedics Limited Overview, Products and Services, Strategy and Financial Analysis

31. Neurodiagnostics Market Other Major And Innovative Companies

• 31.1. Ceribell Inc.
• 31.2. CND Life Sciences Inc.
• 31.3. Lifelines Neuro Inc.
• 31.4. ANT Neuro B.V.
• 31.5. Neurovative Diagnostics LLC
• 31.6. Firefly Neuroscience Inc
• 31.7. IntraNerve Neuroscience Inc
• 31.8. NeuroDiagnostics Laboratories LLC
• 31.9. Advanced Brain Monitoring Inc
• 31.10. Spes Medica S.r.l.
• 31.11. BioSignal Group Inc
• 31.12. Combinostics Inc.
• 31.13. Deymed Diagnostic LLC
• 31.14. NeuLine Health Inc.
• 31.15. Ridge Diagnostics Inc.

32. Global Neurodiagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neurodiagnostics Market

34. Recent Developments In The Neurodiagnostics Market

35. Neurodiagnostics Market High Potential Countries, Segments and Strategies

• 35.1 Neurodiagnostics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Neurodiagnostics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Neurodiagnostics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer